Loading…
Loading…
EQUITY / NASDAQ · XNCM
Minerva Neurosciences Inc.
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗3.28 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 3.28 USD · Volume 57,029
251 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Operating profit | -10,642,159 USD | -3,374,149 USD | — |
| Net income | 17,466,285 USD | -3,258,588 USD | — |
| Cash and cash equivalents | 24,652,086 USD | 15,247,910 USD | +61.68% |
| Total liabilities | 296,648,246 USD | — | — |
| Total equity | -213,300,623 USD | -32,109,213 USD | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 204/01/2025 – 06/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 24,652,086 USD | — | — | 82,301,813 USD | 82,301,813 USD | 12,286,646 USD | — | 15,247,910 USD |
| Net incomeIncome statement | 17,466,285 USD | -107,938,099 USD | -125,404,384 USD | — | -293,423,177 USD | -2,743,954 USD | -9,755,514 USD | -3,258,588 USD |
| Operating profitIncome statement | -10,642,159 USD | -27,313,711 USD | — | — | -15,102,970 USD | -2,844,348 USD | -10,121,381 USD | -3,374,149 USD |
| Total assetsBalance sheet | 95,088,945 USD | — | — | 97,968,888 USD | 97,968,888 USD | 28,092,052 USD | — | — |
| Total equityBalance sheet | -213,300,623 USD | — | -254,013,860 USD | -140,748,082 USD | -140,748,082 USD | -34,580,270 USD | — | -32,109,213 USD |
| Total liabilitiesBalance sheet | 296,648,246 USD | — | — | 233,755,048 USD | 233,755,048 USD | 62,672,322 USD | — | — |
| Financing cash flowCash flow statement | — | 11,249,487 USD | — | — | 74,450,741 USD | — | -45,166 USD | — |
| Investing cash flowCash flow statement | — | -50,127,329 USD | — | — | 0 USD | — | 0 USD | — |
| Operating cash flowCash flow statement | — | -18,771,885 USD | — | — | -13,510,936 USD | — | -9,030,196 USD | — |
| Report source | Open report ↗ Published: 08/07/2026 | Open report ↗ Published: 08/07/2026 | Open report ↗ Published: 08/07/2026 | Open report ↗ Published: 08/07/2026 | Open report ↗ Published: 03/11/2026 | Open report ↗ Published: 11/05/2025 | Open report ↗ Published: 11/05/2025 | Open report ↗ Published: 08/07/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.